Skip to Content

DATA BRIEF: Expanding COVID-19 Testing

Updated on Mar 10, 2022

Early Data from Akadeum’s RNA Extraction Project for Pooled Saliva Samples


Current COVID-19 saliva testing is limited.
Akadeum’s microbubbles aim to change everything.

At Akadeum Life Sciences, we are actively working to develop an innovative cell separation approach that makes pooled saliva testing possible – in an accurate and cost-effective way. We have expanded our microbubble platform by functionalizing our revolutionary buoyancy-activated separation (BACS™) technology for RNA isolation in saliva samples, and we’re optimizing a workflow that allows for quick and easy RNA extraction in larger volume samples to create a platform for pooled saliva testing that can be done at scale.

Early testing shows Akadeum’s microbubbles outperform the standard extraction kit by as much as 25x, while delivering 300% higher concordance with diagnostics.

Download the Data Brief today to get a first look. We are actively finalizing our protocol and entering into the next stage of testing to confirm the validity of results with the full understanding that our work today could lead a to better and brighter tomorrow with increased saliva testing capability available at scale.

Back to Top